US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -162 | -1,048 | -2,254 | -1,247 | 226 |
| Depreciation Amortization | 3 | 1 | 5 | 347 | 2 |
| Accounts receivable | -3 | 17 | -104 | -163 | -114 |
| Accounts payable and accrued liabilities | 243 | 115 | 858 | 629 | 255 |
| Other Working Capital | 506 | 274 | 1,859 | 1,489 | 369 |
| Other Operating Activity | -1,234 | 258 | -1,473 | -1,802 | -1,245 |
| Operating Cash Flow | $-647 | $-384 | $-1,109 | $-747 | $-507 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -8 | -8 | -6 |
| Purchase Of Investment | -10 | -5 | -50 | N/A | N/A |
| Other Investing Activity | -50 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-61 | $-6 | $-58 | $-8 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 322 | 180 | 774 | 415 | 275 |
| Common Stock Issued | 534 | 300 | 616 | 564 | 507 |
| Other Financing Activity | -91 | -55 | -233 | -223 | -223 |
| Financing Cash Flow | $765 | $424 | $1,157 | $756 | $558 |
| Beginning Cash Position | 37 | 37 | 46 | 46 | 46 |
| End Cash Position | 94 | 71 | 37 | 47 | 91 |
| Net Cash Flow | $57 | $34 | $-10 | $0 | $45 |
| Free Cash Flow | |||||
| Operating Cash Flow | -647 | -384 | -1,109 | -747 | -507 |
| Capital Expenditure | -1 | -1 | -8 | -8 | -6 |
| Free Cash Flow | -648 | -385 | -1,117 | -755 | -514 |